Quanterix Corp
NASDAQ:QTRX

Watchlist Manager
Quanterix Corp Logo
Quanterix Corp
NASDAQ:QTRX
Watchlist
Price: 12.06 USD -2.9% Market Closed
Market Cap: 462.9m USD
Have any thoughts about
Quanterix Corp?
Write Note

Gross Margin
Quanterix Corp

57.4%
Current
54%
Average
43.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.4%
=
Gross Profit
74.3m
/
Revenue
129.3m

Gross Margin Across Competitors

Country US
Market Cap 463.1m USD
Gross Margin
57%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Country US
Market Cap 196.2B USD
Gross Margin
41%
Country US
Market Cap 170.9B USD
Gross Margin
60%
Country KR
Market Cap 67.6T KRW
Gross Margin
49%
Country CH
Market Cap 38.5B CHF
Gross Margin
29%
Country US
Market Cap 38.6B USD
Gross Margin
55%
Country US
Market Cap 36.5B USD
Gross Margin
35%
Country US
Market Cap 26.7B USD
Gross Margin
59%
Country US
Market Cap 23.2B USD
Gross Margin
35%
Country US
Market Cap 23B USD
Gross Margin
60%
No Stocks Found

Quanterix Corp
Glance View

Market Cap
463.1m USD
Industry
Life Sciences Tools & Services

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 460 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to reliably detect protein biomarkers at extremely low concentrations in blood, serum and other fluids. Its products include HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, and 2470 Arrayer. The company also supplies NF-Light antibodies and ELISA kits, which offer solutions for the detection of neurofilament light (Nf-L) for the development of therapeutics and diagnostics for neurodegenerative conditions. Its portfolio of available kits spans multiple therapeutic areas, including cardiology, infectious disease, inflammation, neurology, and oncology. The company provides services through its Simoa Accelerator Laboratory.

QTRX Intrinsic Value
17 USD
Undervaluation 29%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.4%
=
Gross Profit
74.3m
/
Revenue
129.3m
What is the Gross Margin of Quanterix Corp?

Based on Quanterix Corp's most recent financial statements, the company has Gross Margin of 57.4%.